文献速递肝病

非酒精性脂肪性肝病中组织学与MRI-PDFF脂肪变分级不一致相关的临床与组织学因素

Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI-PDFF in NAFLD.
PubMed 文献 · Aliment Pharmacol Ther · 2023-06-02

纳入728例活检证实的非酒精性脂肪性肝病患者,比较组织学与MRI-PDFF脂肪变分级,主要不一致率为6.6%,多数为组织学分级更高,且与更高AST、肝硬度及纤维化≥2、气球样变≥1、小叶炎症≥2相关。结论认为组织学较MRI-PDFF高估脂肪变分级,晚期NASH患者更易被组织学上调分级。

要点

  • 组织学与MRI-PDFF脂肪变分级主要不一致率为6.6%(48例)。
  • 不一致病例中88.3%为组织学分级高于MRI-PDFF。
  • 组织学高估与更高AST、肝硬度及纤维化≥2等相关。

核心结论

  • 组织学较MRI-PDFF高估脂肪变分级,晚期NASH患者更易被组织学上调脂肪变分级。

研究设计与样本

  • 纳入728例活检证实的NAFLD患者,其中UC San Diego 414例、Yokohama City University 314例,均接受MRI-PDFF和肝活检。

主要发现

  • 组织学与MRI-PDFF确定的脂肪变分级分布分别为:0级5.5%(40例)vs 23.5%(171例),1级44.8%(326例)vs 49.7%(362例),2级33.9%(247例)vs 12.9%(94例),3级15.8%(115例)vs 13.9%(101例)。
  • 主要不一致率为6.6%(48例),其中多数(40例,88.3%)为组织学分级更高。
  • 主要不一致病例具有更高血清AST和肝硬度,以及更高比例的纤维化≥2、气球样变≥1和小叶炎症≥2(均p < 0.05)。

关键数值与推荐

  • MRI-PDFF分级切点:0级<6.4%,1级6.4%-17.4%,2级17.4%-22.1%,3级≥22.1%。
  • 主要不一致定义为组织学与MRI-PDFF脂肪变分级相差≥2级。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Magnetic resonance imaging-proton density fat fraction (MRI-PDFF) is an excellent biomarker for the non-invasive quantification of hepatic steatosis. AIM: To examine clinical and histologic factors associated with discordance between steatosis grade determined by histology and MRI-PDFF in patients with non-alcoholic fatty liver disease (NAFLD) METHODS: We included 728 patients with biopsy-proven NAFLD from UC San Diego (n = 414) and Yokohama City University (n = 314) who underwent MRI-PDFF and liver biopsy. Patients were stratified by steatosis, and matched with MRI-PDFF cut-points for each steatosis grade: 0 (MRI-PDFF < 6.4%), 1 (MRI-PDFF: 6.4%-17.4%), 2 (MRI-PDFF: 17.4%-22.1%), 3 (MRI-PDFF ≥ 22.1%). Primary outcome was major discordance defined as ≥2 steatosis grade difference determined by histology and MRI-PDFF. RESULTS: Mean (±SD) age and BMI were 55.3 (±13.8) years and 29.9 (±4.9) kg/m2 , respectively. The distributions of histology and MRI-PDFF-determined steatosis were 5.5% grade 0 (n = 40), 44.8% 1 (n = 326, 44.8%), 33.9% 2 (n = 247), and 15.8% 3 (n = 115) vs. 23.5% grade 0 (n = 171), 49.7% 1 (n = 362), 12.9% 2 (n = 94), and 13.9% 3 (n = 101). Major discordance rate was 6.6% (n = 48). Most cases with major discordance had greater histology-determined steatosis grade (n = 40, 88.3%), higher serum AST and liver stiffness, and greater likelihood of fibrosis ≥2, ballooning ≥1 and lobular inflammation ≥2 (all p < 0.05). CONCLUSION: Histology overestimates steatosis grade compared to MRI-PDFF. Patients with advanced NASH are likely to be upgraded on steatosis grade by histology. These data have important implications for steatosis estimation and reporting on histology in clinical practice and trials, especially in patients with stage 2 fibrosis.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Kim BK, Bernstein N, Huang DQ, et al. Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI-PDFF in NAFLD. Aliment Pharmacol Ther. 2023. PMID: 37269117. doi:10.1111/apt.17564

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。